More about

Immunotherapy

News
March 31, 2022
2 min read
Save

Blood-based microRNA signature may predict survival in immunotherapy-treated NSCLC

Blood-based microRNA signature may predict survival in immunotherapy-treated NSCLC

A blood-based signature of five microRNAs demonstrated the ability to predict OS of patients with lung cancer receiving immunotherapy and stratify them for treatment, according to a study published in npj Precision Oncology.

News
March 30, 2022
3 min read
Save

Celebrate National Doctors’ Day with advice from top allergy, asthma specialists

Celebrate National Doctors’ Day with advice from top allergy, asthma specialists

As Healio celebrates National Doctors' Day today, we recognize dedicated physicians we spoke with over the past year about how they are working both in the clinic and beyond to improve allergy, asthma and immunology care.

News
March 24, 2022
2 min read
Save

MD Anderson launches James P. Allison immunotherapy institute to ‘enable cures’ for cancer

MD Anderson launches James P. Allison immunotherapy institute to ‘enable cures’ for cancer

The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a research and innovation hub that integrates immunobiology across disciplines to accelerate discoveries toward cancer cures.

News
March 16, 2022
3 min read
Save

Microneedle patch shows potential as option for peanut immunotherapy

Microneedle patch shows potential as option for peanut immunotherapy

Peanut-coated microneedles may represent a safe and effective alternative to epicutaneous immunotherapy, according to a study published in Immunotherapy.

News
March 07, 2022
1 min read
Save

Predictors improve peanut OIT safety for preschoolers

Predictors improve peanut OIT safety for preschoolers

PHOENIX — Researchers identified predictive factors of grade 2 or worse reactions during peanut OIT in preschoolers, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
March 03, 2022
4 min read
Save

Management strategies aim to help allergy practices evolve, expand, succeed

Management strategies aim to help allergy practices evolve, expand, succeed

PHOENIX — With new treatments, technologies and billing policies, providers may feel like they are falling behind their competition and failing their patients and their practices. Strategies and resources, however, are available.

News
February 19, 2022
2 min read
Save

Immune cell parameters linked to therapeutic efficacy in advanced renal cell carcinoma

SAN FRANCISCO — Certain immune cell-related parameters appeared associated with efficacy of immune checkpoint inhibitors among patients with advanced or metastatic clear cell renal cell carcinoma, according to study results.

News
February 17, 2022
1 min read
Save

Top in hem/onc: Antihistamine use in patients with cancer, missed screenings amid COVID-19

Top in hem/onc: Antihistamine use in patients with cancer, missed screenings amid COVID-19

Researchers conducted a study to determine whether commonly used medications influence responses to cancer treatment. They found that antihistamines were associated with improved immunotherapy efficacy.

News
January 25, 2022
3 min read
Save

Real-world data show oral immunotherapy for peanut allergy is safe, effective in infants

Real-world data show oral immunotherapy for peanut allergy is safe, effective in infants

In a real-world setting, peanut oral immunotherapy was safer in infants aged 12 months or younger than in children aged 1 to 5 years, according to recent data.

News
January 21, 2022
4 min read
Save

Oral immunotherapy may lead to remission of peanut allergy in young children

Oral immunotherapy may lead to remission of peanut allergy in young children

Oral immunotherapy was associated with an increase in both desensitization and remission of peanut allergy among children aged younger than 4 years, with younger children seeing greater success, according to data published in The Lancet.

View more